Serum ADAMTS-13 Levels as an Indicator of Portal Vein Thrombosis
Background. Coagulation disorders in patients with liver cirrhosis are a common clinical problem. Cirrhosis should be considered a state of impaired blood clotting or an imbalance of the whole coagulation system. Cirrhosis-induced coagulopathy encompasses disturbances in both the procoagulant and an...
Saved in:
| Main Authors: | Tomasz Mikuła, Joanna Kozłowska, Wojciech Stańczak, Mariusz Sapuła, Aleksandra Różyk, Alicja Wiercińska-Drapało |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018-01-01
|
| Series: | Gastroenterology Research and Practice |
| Online Access: | http://dx.doi.org/10.1155/2018/3287491 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In Search of Risk Factors for Recurrent Erysipelas and Cellulitis of the Lower Limb: A Cross-Sectional Study of Epidemiological Characteristics of Patients Hospitalized due to Skin and Soft-Tissue Infections
by: Mariusz Sapuła, et al.
Published: (2020-01-01) -
Normal Glypican-3 Serum Levels Do Not Eliminate the Risk of Hepatocellular Carcinoma
by: Agnieszka Lembas, et al.
Published: (2024-09-01) -
Proinflammatory Biomarkers and Clinical Factors Associated with Long-Term Mortality in People with HIV
by: Agnieszka Lembas, et al.
Published: (2025-02-01) -
Portal vein thrombosis in COVID-19 infection
by: Stefanie Sinz, et al.
Published: (2021-04-01) -
Portal vein thrombosis in patients with liver cirrhosis
by: Savić Željka, et al.
Published: (2024-01-01)